Asymchem Laboratories (HKG:6821, SHE:002821) posted 331.7 million yuan in profit attributable to shareholders of the listed company for the third quarter, up 81% from a year ago.

EPS moved to 0.91 yuan, a Thursday filing with the Hong Kong Exchange showed.

For the three months ended Sept. 30, operating revenue was 1.79 billion yuan, an increase of 24% from the year-ago period, the pharmaceutical outsourcing services company said.